Literature DB >> 10748522

Enzymatic incorporation of bioactive peptides into fibrin matrices enhances neurite extension.

J C Schense1, J Bloch, P Aebischer, J A Hubbell.   

Abstract

Fibrin plays an important role in wound healing and regeneration, and enjoys widespread use in surgery and tissue engineering. The enzymatic activity of Factor XIIIa was employed to covalently incorporate exogenous bioactive peptides within fibrin during coagulation. Fibrin gels were formed with incorporated peptides from laminin and N-cadherin alone and in combination at concentrations up to 8.2 mol peptide per mole of fibrinogen. Neurite extension in vitro was enhanced when gels were augmented with exogenous peptide, with the maximal improvement reaching 75%. When this particular fibrin derivative was evaluated in rats in the repair of the severed dorsal root within polymeric tubes, the number of regenerated axons was enhanced by 85% relative to animals treated with tubes filled with unmodified fibrin. These results demonstrate that it is possible to enhance the biological activity of fibrin by enzymatically incorporating exogenous oligopeptide domains of morphoregulatory proteins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10748522     DOI: 10.1038/74473

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  51 in total

1.  Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery.

Authors:  C P Hofstetter; E J Schwarz; D Hess; J Widenfalk; A El Manira; Darwin J Prockop; L Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

2.  Advantages of RGD peptides for directing cell association with biomaterials.

Authors:  Susan L Bellis
Journal:  Biomaterials       Date:  2011-06       Impact factor: 12.479

Review 3.  A biomaterials approach to peripheral nerve regeneration: bridging the peripheral nerve gap and enhancing functional recovery.

Authors:  W Daly; L Yao; D Zeugolis; A Windebank; A Pandit
Journal:  J R Soc Interface       Date:  2011-11-16       Impact factor: 4.118

4.  The role of a recombinant fragment of laminin-332 in integrin alpha3beta1-dependent cell binding, spreading and migration.

Authors:  Hironobu Yamashita; Manisha Tripathi; Mark P Harris; Shanshan Liu; Brandy Weidow; Roy Zent; Vito Quaranta
Journal:  Biomaterials       Date:  2010-03-27       Impact factor: 12.479

5.  Neuronal progenitor cells seeded in fibrin gel differentiate into ChAT-positive neuron.

Authors:  Jinbo Liu; Zhijian Zhang; Aihua Gong; Xudong Cao; Leimin Qian; Lirong Duan; Xianglan Sun; Xuefeng Bu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-07-13       Impact factor: 2.416

6.  Maleimide-thiol coupling of a bioactive peptide to an elastin-like protein polymer.

Authors:  Swathi Ravi; Venkata R Krishnamurthy; Jeffrey M Caves; Carolyn A Haller; Elliot L Chaikof
Journal:  Acta Biomater       Date:  2011-10-25       Impact factor: 8.947

7.  A neuroinductive biomaterial based on dopamine.

Authors:  Jin Gao; Yu Mi Kim; Herna Coe; Blaine Zern; Barbara Sheppard; Yadong Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-30       Impact factor: 11.205

8.  Composite fibrin scaffolds increase mechanical strength and preserve contractility of tissue engineered blood vessels.

Authors:  Lan Yao; Jinyu Liu; Stelios T Andreadis
Journal:  Pharm Res       Date:  2007-12-19       Impact factor: 4.200

Review 9.  Complexity in biomaterials for tissue engineering.

Authors:  Elsie S Place; Nicholas D Evans; Molly M Stevens
Journal:  Nat Mater       Date:  2009-06       Impact factor: 43.841

10.  Long-lasting fibrin matrices ensure stable and functional angiogenesis by highly tunable, sustained delivery of recombinant VEGF164.

Authors:  Veronica Sacchi; Rainer Mittermayr; Joachim Hartinger; Mikaël M Martino; Kristen M Lorentz; Susanne Wolbank; Anna Hofmann; Remo A Largo; Jeffrey S Marschall; Elena Groppa; Roberto Gianni-Barrera; Martin Ehrbar; Jeffrey A Hubbell; Heinz Redl; Andrea Banfi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.